Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Ling-Pei Ho, who was awarded £872K to study an exciting new research avenue in lung fibrosis.

A low power scanning electron micrograph of alveoli of the human lung © Credit: David Gregory & Debbie Marshall CC BY 4.0

The lung has a remarkable capacity for regeneration, with a whole new segment being able to regenerate following injury or surgery. This regenerative capacity is due to the existence of adult stem cells in the lungs that can potentially be harnessed for patients with advanced lung fibrosis.

Organ regeneration occurs within a complex micro-environment (or 'niche'), unique to each organ, in which the adult stem cells communicate with each other and with the surrounding structural cells. Current research has focused  primarily on the constituents of this ‘niche’. The new grant awarded to Prof Ling-Pei Ho by the MRC - UK Regenerative Medicine Platform will specifically explore the contribution of niche-resident immune cells to regeneration.

Despite a lot of work on the niche, little is known of how immune cells, in particular those that stably reside in the niche (“tissue-resident immune cells”), influence regeneration. We are interested in the role of these tissue-resident immune cells in promoting regeneration after injury - Prof Ho


Prof Ho will lead a network of collaborators from King's College London, Newcastle and the Gurdon Institute in Cambridge in this endeavour. The programme will take advantage of advanced technologies such as single cell RNA sequencing, mass cytometry, and gene editing. The team aims to build a detailed view of how the immune system impacts on the regeneration potential of the lungs following injury.

Ultimately, deeper understanding of this area will pave the way for development of new therapies to promote the regrowth of the lung in patients with lung fibrosis (specifically idiopathic pulmonary fibrosis).


Ling-Pei is an Associate Professor of Respiratory Immunology in the Nuffield Department of Medicine, and a Consultant in Respiratory Medicine. Her research group is based at the MRC Human Immunology Unit.

Similar stories

Many Long COVID patients continue to experience symptoms one year after hospital discharge

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.

$2m awarded to explore the role of ancestry in vaccine response

The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.

Joe Frost wins 2021 RDM graduate prize

Many congratulations to Dr Frost.

Join us at the IF Science and Ideas Festival

Come down to Templars Shopping Centre on 23rd or 24th October 2021 for ‘Science at the Shops’ as part of IF Oxford Science and Ideas Festival.